Effect of ROR1-targeting small molecules on chronic lymphocytic leukemia (CLL) cells.Håkan Mellstedt, Ali Moshfegh, Anders Österborg et al.|Journal of Clinical Oncology|2012Cited by 7
A new class of compound for pancreatic carcinoma targeting the tyrosine kinase receptor (TKR) ROR1.Håkan Mellstedt, Anders Österborg, Amir Hossein Daneshmanesh et al.|Journal of Clinical Oncology|2014Cited by 5
A new class of anti-cancer drugs targeting the tyrosine kinase receptor ROR1 in CLL.Håkan Mellstedt, Ali Moshfegh, Salam Khan et al.|Journal of Clinical Oncology|2015Cited by 4
Apoptosis induction mediated through PI3-kinase/AKT/mTOR pathway using anti-ROR1 monoclonal antibody in chronic lymphocytic leukemia cells.Amir Hossein Daneshmanesh, Håkan Mellstedt, Salam Khan et al.|Journal of Clinical Oncology|2013Cited by 2